medigraphic.com
ISSN 2448-8909 (Print)

2008, Number 1

<< Back Next >>

Med Crit 2008; 22 (1)

Delta cardiac power in septic shock

Monares ZE, Arcos ZM, Sánchez CC, Colín EV, Etulain GJE, Poblano MM, Aguirre SJ, Martínez SJ

Language: Spanish
References: 14
Page: 15-19
PDF size: 93.56 Kb.


ABSTRACT

Introduction: The cardiac power (CP) is an estimation of the function of bomb of the heart.
Objective: To assess the utility of the CP in the prognosis of patients with septic shock (SS).
Material and methods: Prospective study, including patients (p) with diagnosis of SS and Swan-Ganz catheter from January to August 2006. The CP delta (D), haemodynamic variables, and oxygen transport were measured at beginning of the study and 24 hrs later.
Results: A total of 23 p, divided in two groups: Survivers n = 13, CP 0.6 (0.5-1.25) D PC 75 (33-100). Not survivers n = 10, PC 0.85 (0.8-1.07) D PC -31 (-40 – 0). The D PC when stays constant or decreases, predicts mortality with an 80% sensibility and 84.6% specificity, area under the curve ROC of 0.82.
Conclusions: The D PC at 24 hrs is a predictor of mortality in SS.


REFERENCES

  1. Nicholls W. Haemodynamics. J Physiol 1896;20:407-426.

  2. Evans CL. The velocity factor in cardiac work. J Physiol 1918;52:6-14.

  3. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G. SHOCK Investigators. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 2004;44:340-8.

  4. Firstenberg MS, Armstrong G, Greenberg NL, Garcia MJ, Thomas JD. Different estimates of cardiac power: relationship to altered loading conditions. Computers in Cardiology 2002;29:713-6.

  5. Cotter G, Williams SG, Vered Z, Tan LB. Role of cardiac power in heart failure. Currt Opin in Cardio 2003;18(3): 215-22.

  6. Dellinger R P. Cardiovascular management of septic shock. Critical Care Medicine 2003; 31(3):946-955.

  7. Baumgartner J, Vaney C, Perret C. An extreme form of hyperdynamic syndrome in septic shock. Intensive Care Med 1984;10:245-249.

  8. Parker SM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE. Serial cardiovascular variables in survivors and non-survivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 1987;15: 923-929.

  9. Lupi HE, Chuquiure VE, González PH et al. «El poder cardíaco» un instrumento del pasado, posiblemente una herramienta moderna en la valoración clínica, terapéutica y pronóstica del choque cardiogénico por síndrome isquémico coronario agudo. Arch Cardiol Mex 2006;76: 95-108.

  10. Gattinoni L, Brazzi L, Pelosi P et al. A trial of goal-oriented hemodynamic therapy in critically ill patients: SvO2 Collaborative Group. N Engl J Med 1995;333:1025-1032.

  11. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377.

  12. Vallet B, Curtis SE, Chopin C. Prognostic value of the dobutamine test in patients with sepsis syndrome. Critical Care Medicine 1995;23(2):415.

  13. Levy MM, Fink MP, Marshall JC et al. 2001SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 2003;29:530-538.

  14. Court O, Kumar A, Parrillo JE. Clinical review: Myocardial depression in sepsis and septic shock. Critical Care 2002;6:500-508.




2020     |     www.medigraphic.com